Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jaspreet S Brar

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Neuropsychiatric Disease and Treatment|May 5, 2009
Dose-dependent rapid-onset akathisia with aripiprazole in patients with schizoaffective disorderRanita Basu, Jaspreet S Brar
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|November 16, 2012
Health-related quality of life, adiposity, and sedentary behavior in patients with early schizophrenia: preliminary studyMartin Strassnig, Jaspreet S Brar, Rohan Ganguli
Journal of Ayurveda and Integrative Medicine|July 16, 2011
"Does one shoe fit all?"Jaspreet S Brar, K N R Chengappa
Schizophrenia Research|December 15, 2010
Low cardiorespiratory fitness and physical functional capacity in obese patients with schizophreniaMartin Strassnig, Jaspreet S Brar, Rohan Ganguli
Schizophrenia Research|May 12, 2005
Self-reported body weight perception and dieting practices in community-dwelling patients with schizophreniaMartin Strassnig, Jaspreet S Brar, Rohan Ganguli
Schizophrenia Research|July 25, 2006
Increased caffeine and nicotine consumption in community-dwelling patients with schizophreniaMartin Strassnig, Jaspreet S Brar, Rohan Ganguli
Clinical Schizophrenia & Related Psychoses|June 23, 2011
Changes in weight and other metabolic indicators in persons with schizophrenia following a switch to aripiprazoleRohan Ganguli, Jaspreet S Brar, Ronald Garbut, et al.
Focus (American Psychiatric Publishing)|January 30, 2026
Why Not Rock the Boat? Deprescribing Anticholinergic Medications That Are No Longer Needed in Persons With SchizophreniaJessica M Gannon, Kadiamada N Roy Chengappa, Ana M Lupu, et al.
The Journal of Clinical Psychiatry|February 12, 2005
Effects of behavioral therapy on weight loss in overweight and obese patients with schizophrenia or schizoaffective disorderJaspreet S Brar, Rohan Ganguli, Gahan Pandina, et al.
The Journal of Clinical Psychiatry|July 12, 2018
Adjunctive Use of a Standardized Extract of Withania somnifera (Ashwagandha) to Treat Symptom Exacerbation in Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled StudyK N Roy Chengappa, Jaspreet S Brar, Jessica M Gannon, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Neuropsychiatric Disease and Treatment|May 5, 2009
Dose-dependent rapid-onset akathisia with aripiprazole in patients with schizoaffective disorderRanita Basu, Jaspreet S Brar
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|November 16, 2012
Health-related quality of life, adiposity, and sedentary behavior in patients with early schizophrenia: preliminary studyMartin Strassnig, Jaspreet S Brar, Rohan Ganguli
Journal of Ayurveda and Integrative Medicine|July 16, 2011
"Does one shoe fit all?"Jaspreet S Brar, K N R Chengappa
Schizophrenia Research|December 15, 2010
Low cardiorespiratory fitness and physical functional capacity in obese patients with schizophreniaMartin Strassnig, Jaspreet S Brar, Rohan Ganguli
Schizophrenia Research|May 12, 2005
Self-reported body weight perception and dieting practices in community-dwelling patients with schizophreniaMartin Strassnig, Jaspreet S Brar, Rohan Ganguli
Schizophrenia Research|July 25, 2006
Increased caffeine and nicotine consumption in community-dwelling patients with schizophreniaMartin Strassnig, Jaspreet S Brar, Rohan Ganguli
Clinical Schizophrenia & Related Psychoses|June 23, 2011
Changes in weight and other metabolic indicators in persons with schizophrenia following a switch to aripiprazoleRohan Ganguli, Jaspreet S Brar, Ronald Garbut, et al.
Focus (American Psychiatric Publishing)|January 30, 2026
Why Not Rock the Boat? Deprescribing Anticholinergic Medications That Are No Longer Needed in Persons With SchizophreniaJessica M Gannon, Kadiamada N Roy Chengappa, Ana M Lupu, et al.
The Journal of Clinical Psychiatry|February 12, 2005
Effects of behavioral therapy on weight loss in overweight and obese patients with schizophrenia or schizoaffective disorderJaspreet S Brar, Rohan Ganguli, Gahan Pandina, et al.
The Journal of Clinical Psychiatry|July 12, 2018
Adjunctive Use of a Standardized Extract of Withania somnifera (Ashwagandha) to Treat Symptom Exacerbation in Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled StudyK N Roy Chengappa, Jaspreet S Brar, Jessica M Gannon, et al.
Pageof 5